Aaron Osborne

2.2k total citations
37 papers, 1.7k citations indexed

About

Aaron Osborne is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Molecular Biology. According to data from OpenAlex, Aaron Osborne has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Ophthalmology and 7 papers in Molecular Biology. Recurrent topics in Aaron Osborne's work include Retinal Imaging and Analysis (17 papers), Retinal Diseases and Treatments (16 papers) and Retinal and Optic Conditions (7 papers). Aaron Osborne is often cited by papers focused on Retinal Imaging and Analysis (17 papers), Retinal Diseases and Treatments (16 papers) and Retinal and Optic Conditions (7 papers). Aaron Osborne collaborates with scholars based in United States, Austria and Switzerland. Aaron Osborne's co-authors include Ursula Schmidt‐Erfurth, Amir Sadeghipour, Hrvoje Bogunović, Sebastian M. Waldstein, Bianca S. Gerendas, Georg Langs, Thomas Schlegl, Frank G. Holz, Arshad M. Khanani and Jayashree Sahni and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Aaron Osborne

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Osborne United States 21 1.2k 1.1k 300 89 83 37 1.7k
Vincenza Bonfiglio Italy 28 1.4k 1.1× 941 0.9× 316 1.1× 61 0.7× 128 1.5× 94 1.8k
Roberto Gallego‐Pinazo Spain 26 2.2k 1.8× 1.3k 1.2× 471 1.6× 66 0.7× 39 0.5× 166 2.5k
Marco Nassisi United States 26 1.7k 1.4× 1.3k 1.2× 351 1.2× 44 0.5× 26 0.3× 72 2.0k
Johanna M. Colijn Netherlands 16 561 0.5× 435 0.4× 336 1.1× 46 0.5× 44 0.5× 21 1.0k
Francesco Oddone Italy 33 2.6k 2.2× 1.8k 1.6× 476 1.6× 66 0.7× 37 0.4× 173 3.1k
Robert Honkanen United States 20 1.3k 1.1× 877 0.8× 326 1.1× 66 0.7× 21 0.3× 54 1.8k
John Kerrison United States 23 753 0.6× 304 0.3× 588 2.0× 53 0.6× 43 0.5× 46 1.6k
Sieun Lee Canada 18 600 0.5× 636 0.6× 301 1.0× 68 0.8× 36 0.4× 79 1.2k
Takashi Kanamoto Japan 15 603 0.5× 484 0.4× 342 1.1× 53 0.6× 25 0.3× 37 1.0k
Maria Cristina Savastano Italy 25 1.6k 1.3× 1.2k 1.1× 294 1.0× 78 0.9× 20 0.2× 132 2.0k

Countries citing papers authored by Aaron Osborne

Since Specialization
Citations

This map shows the geographic impact of Aaron Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Osborne more than expected).

Fields of papers citing papers by Aaron Osborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Osborne. The network helps show where Aaron Osborne may publish in the future.

Co-authorship network of co-authors of Aaron Osborne

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Osborne. A scholar is included among the top collaborators of Aaron Osborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Osborne. Aaron Osborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blodi, Barbara A., et al.. (2023). Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 7(8). 661–671. 10 indexed citations
2.
Banerjee, Imon, Luís de Sisternes, Joelle Hallak, et al.. (2020). Prediction of age-related macular degeneration disease using a sequential deep learning approach on longitudinal SD-OCT imaging biomarkers. Scientific Reports. 10(1). 15434–15434. 50 indexed citations
3.
Sahni, Jayashree, Sunil Patel, Pravin U. Dugel, et al.. (2019). Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema. Ophthalmology. 126(8). 1155–1170. 179 indexed citations
4.
Macdermid, Paul W., Aaron Osborne, & Stephen R. Stannard. (2019). Mechanical Work and Physiological Responses to Simulated Flat Water Slalom Kayaking. Frontiers in Physiology. 10. 260–260. 12 indexed citations
5.
Hallak, Joelle, Luís de Sisternes, Aaron Osborne, et al.. (2019). Imaging, Genetic, and Demographic Factors Associated With Conversion to Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology. 137(7). 738–738. 30 indexed citations
6.
Schmidt‐Erfurth, Ursula, Hrvoje Bogunović, Sophie Klimscha, et al.. (2017). Machine learning to predict the individual progression of AMD from imaging biomarkers. Investigative Ophthalmology & Visual Science. 58(8). 3398–3398. 2 indexed citations
7.
Seeböck, Philipp, Sebastian M. Waldstein, René Donner, et al.. (2017). Defining disease endophenotypes in neovascular AMD by unsupervised machine learning of large-scale OCT data. Investigative Ophthalmology & Visual Science. 58(8). 56–56. 1 indexed citations
8.
Schmidt‐Erfurth, Ursula, Hrvoje Bogunović, Amir Sadeghipour, et al.. (2017). Machine Learning to Analyze the Prognostic Value of Current Imaging Biomarkers in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2(1). 24–30. 135 indexed citations
9.
Chong, Victor, Winfried M. K. Amoaku, Jonathan Alsop, & Aaron Osborne. (2013). Effectiveness of quarterly (Q3M) versus monthly (QM) ranibizumab according to initial gains in visual acuity - an analysis of 12 month data from the EXCITE study. Investigative Ophthalmology & Visual Science. 54(15). 3816–3816. 2 indexed citations
10.
Tufail, Adnan, Praveen J. Patel, Sobha Sivaprasad, et al.. (2013). Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study. Eye. 27(6). 709–715. 38 indexed citations
11.
Tufail, Adnan, Nirodhini Narendran, Praveen J. Patel, et al.. (2013). Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study. Ophthalmology. 120(9). 1944–1945.e1. 76 indexed citations
12.
Osborne, Aaron, Hongquan Zhang, & George Blanck. (2005). Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line. Molecular Immunology. 43(6). 710–716. 4 indexed citations
13.
Osborne, Aaron, et al.. (2004). Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells. Journal of Biological Chemistry. 279(28). 28911–28919. 23 indexed citations
14.
Osborne, Aaron, et al.. (2004). Identification of insulin-responsive regions in the HMG-CoA reductase promoter. Biochemical and Biophysical Research Communications. 318(4). 814–818. 21 indexed citations
15.
Osborne, Aaron, Hongquan Zhang, Wen‐Ming Yang, Edward Seto, & George Blanck. (2001). Histone Deacetylase Activity Represses Gamma Interferon-Inducible HLA-DR Gene Expression following the Establishment of a DNase I-Hypersensitive Chromatin Conformation. Molecular and Cellular Biology. 21(19). 6495–6506. 36 indexed citations
16.
Mullan, Michael, Paul Scibelli, Ranjan Duara, et al.. (1996). Familial and Population‐Based Studies of Apolipoprotein E and Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 802(1). 16–26. 22 indexed citations
17.
Osborne, Aaron & Roberto Refinetti. (1995). Effects of hypothalamic lesions on the body temperature rhythm of the golden hamster. Neuroreport. 6(16). 2187–2192. 25 indexed citations
18.
Crawford, Fiona, Jonathan Hoyne, Patricia Jaramillo, et al.. (1995). Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder. American Journal of Medical Genetics. 60(4). 332–334. 11 indexed citations
19.
Poduslo, Shirley E., Daniel W. Riggs, John D. Schwankhaus, et al.. (1995). Association of apolipoprotein E but not B with Alzheimer's disease. Human Genetics. 96(5). 597–600. 9 indexed citations
20.
Crawford, Fiona, Aaron Osborne, Patricia Jaramillo, et al.. (1995). Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. American Journal of Medical Genetics. 60(1). 1–6. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026